To test if increased pannexin‐1 activity underlies the hypocalcemia and hypomagnesemia observed in iKsp‐Pkd1−/− mice, mice were treated with the pannexin‐1 inhibitor BB‐FCF for 26 days. The gene discussed is PKD1; the disease is familial primary hypomagnesemia.